Kither Biotech has started dosing patients in its phase 1b / 2a clinical study of KIT2014 in adults with moderate to severe ...

Teva has received US FDA approval for DEGEVMA (denosumab‑adet), a biosimilar to Xgeva, marking a further step in its Pivot to Growth strategy. The product is authorised across all Xgeva indications, ...

Lexeo Therapeutics has signed an agreement to acquire Mantle Therapeutics and launched several new collaborations aimed at ...

AbbVie has received European Commission approval for Rinvoq to treat active polyarticular juvenile idiopathic arthritis in ...

It is a testament to investor success that over 100 exhibitors at CPHI 2026 have some form of PE ownership across the entire ...

Neuraxpharm and Minoryx have announced that the European Commission has granted marketing authorisation under exceptional ...

AC Immune has reported positive week-100 results from part 1 of its phase 2 VacSyn trial evaluating ACI-7104 in early-stage ...

Maternity care is one of the most fundamental components of any healthcare system. It shapes not only the health of mothers ...

For years, the functional service provider (FSP) model has given sponsors a practical way to extend internal teams and access ...

Grünenthal has entered a new partnership with DKSH to expand access to four established pain medicines across Asia-Pacific.

Grünenthal has agreed to acquire Stivarga, an oral treatment for advanced cancers, from Bayer AG for up to €375 million. The company said the deal aligns with its strategy to purchase established ...

Ethiopia, Norway and the UK have pledged US$240 million to support CEPI’s five‑year plan to strengthen global readiness for epidemic and pandemic threats. Ethiopia will contin ...